PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

Pharmaceutical Technology

NOVEMBER 9, 2022

Despite their potential multi-million-dollar sticker price, if haemophilia treatments by BioMarin and CSL Behring prove durable, they could help patients save money compared to current treatments, experts note. In the EU however, two years later, the European Commission awarded a conditional marketing authorisation for Roctavian.

FDA 111

FDA 111

pharmaphorum

SEPTEMBER 15, 2020

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

Communication 114

Communication Documentation Labelling Vaccines 114

The Checkup by Singlecare

JANUARY 25, 2023

When asked whether they were concerned about sunburn, photoaging (wrinkles or leathery skin), precancerous skin conditions, or skin cancer, 29% of those surveyed said they weren’t concerned about any of these things. 30% were concerned about the condition, almost as many as those who didn’t have any concerns at all.

Documentation 52

Documentation Insurance FDA 52

European Pharmaceutical Review

DECEMBER 27, 2023

2,3 Clinical implementation of CAR T-cell technology requires a reproducible T-cell manufacturing platform, which necessitates effective gene-transfer tools and T-cell culture conditions. This is in addition to its considerable price tag.

Adverse Reactions 83

Adverse Reactions Immunization Medical Schools Chemotherapy 83